In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo in patients with limited-stage small cell lung cancer ...

Key Takeaways Merck's shares have lost 25.6% in the past six months compared with a decline of 11.7% for the industry. The Zacks Consensus Estimate for 2024 earnings declined from $7.82 to $7.72 per ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

A woman who was diagnosed with stage 4 lung cancer has revealed the biggest lie she was told about the disease, urging others ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...